Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2024 Filed Feb 16, 2024 14:13 UTC |
Puche LuisaChief Financial Officer
|
Disposition to issuerOption to Purchase Common Stock · Derivative | 80,000 | Not disclosed Strike: $2.15 | Not disclosed |
DisclosureSEC source: 0001731122-24-000264 · ownership.xml · derivative · entry 7 Puche Luisa · CIK 0001768468 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,000 shares Expires 2032-10-18 F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options. F5 · derivative.exercise_date: One third of the option vested on October 18, 2023, the remainder of the option vests equally on October 18, 2024 and October 18, 2025. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 14:13 UTC |
Puche LuisaChief Financial Officer
|
GrantOption to Purchase Common Stock · Derivative | 75,000 | Not disclosed Strike: $1.92 | Not disclosed |
DisclosureSEC source: 0001731122-24-000264 · ownership.xml · derivative · entry 6 Puche Luisa · CIK 0001768468 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-07-22 F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 14:13 UTC |
Puche LuisaChief Financial Officer
|
Disposition to issuerOption to Purchase Common Stock · Derivative | 75,000 | Not disclosed Strike: $2.38 | Not disclosed |
DisclosureSEC source: 0001731122-24-000264 · ownership.xml · derivative · entry 5 Puche Luisa · CIK 0001768468 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,000 shares Expires 2032-07-22 F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options. F4 · derivative.exercise_date: The option vested on January 22, 2023. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 14:13 UTC |
Puche LuisaChief Financial Officer
|
GrantOption to Purchase Common Stock · Derivative | 60,000 | Not disclosed Strike: $1.92 | Not disclosed |
DisclosureSEC source: 0001731122-24-000264 · ownership.xml · derivative · entry 4 Puche Luisa · CIK 0001768468 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2031-10-26 F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 14:13 UTC |
Puche LuisaChief Financial Officer
|
Disposition to issuerOption to Purchase Common Stock · Derivative | 60,000 | Not disclosed Strike: $8.58 | Not disclosed |
DisclosureSEC source: 0001731122-24-000264 · ownership.xml · derivative · entry 3 Puche Luisa · CIK 0001768468 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2031-10-26 F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options. F3 · derivative.exercise_date: The option vested in three equal installments on October 26, 2021, October 26, 2022 and October 26, 2023. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 14:13 UTC |
Puche LuisaChief Financial Officer
|
GrantOption to Purchase Common Stock · Derivative | 60,000 | Not disclosed Strike: $1.92 | Not disclosed |
DisclosureSEC source: 0001731122-24-000264 · ownership.xml · derivative · entry 2 Puche Luisa · CIK 0001768468 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2029-06-06 F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 14:13 UTC |
Puche LuisaChief Financial Officer
|
Disposition to issuerOption to Purchase Common Stock · Derivative | 60,000 | Not disclosed Strike: $6.15 | Not disclosed |
DisclosureSEC source: 0001731122-24-000264 · ownership.xml · derivative · entry 1 Puche Luisa · CIK 0001768468 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2029-06-06 F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options. F1 · derivative.exercise_date: The option vested in three equal installments on January 7, 2019, January 7, 2020 and January 7, 2021. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 14:06 UTC |
Dybul MarkDirector · Chief Executive Officer
|
GrantOption to Purchase Common Stock · Derivative | 350,000 | Not disclosed Strike: $1.92 | Not disclosed |
DisclosureSEC source: 0001731122-24-000263 · ownership.xml · derivative · entry 12 Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2032-08-25 F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options. F4 · derivative.exercise_date: One third of the option vested on August 25, 2023. The remainder of the option shall vest in two equal installments on August 25, 2024 and August 25, 2025. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 14:06 UTC |
Dybul MarkDirector · Chief Executive Officer
|
Disposition to issuerOption to Purchase Common Stock · Derivative | 350,000 | Not disclosed Strike: $2.54 | Not disclosed |
DisclosureSEC source: 0001731122-24-000263 · ownership.xml · derivative · entry 11 Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 350,000 shares Expires 2032-08-25 F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options. F4 · derivative.exercise_date: One third of the option vested on August 25, 2023. The remainder of the option shall vest in two equal installments on August 25, 2024 and August 25, 2025. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 14:06 UTC |
Dybul MarkDirector · Chief Executive Officer
|
GrantOption to Purchase Common Stock · Derivative | 2,000,000 | Not disclosed Strike: $1.92 | Not disclosed |
DisclosureSEC source: 0001731122-24-000263 · ownership.xml · derivative · entry 10 Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000,000 Underlying: Common Stock · 2,000,000 shares Expires 2031-07-19 F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options. F3 · derivative.exercise_date: The option vested in two equal installments on July 1, 2022 and July 1, 2023. The remainder of the option vests on July 1, 2024. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 14:06 UTC |
Dybul MarkDirector · Chief Executive Officer
|
Disposition to issuerOption to Purchase Common Stock · Derivative | 2,000,000 | Not disclosed Strike: $4.57 | Not disclosed |
DisclosureSEC source: 0001731122-24-000263 · ownership.xml · derivative · entry 9 Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000,000 shares Expires 2031-07-19 F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options. F3 · derivative.exercise_date: The option vested in two equal installments on July 1, 2022 and July 1, 2023. The remainder of the option vests on July 1, 2024. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 14:06 UTC |
Dybul MarkDirector · Chief Executive Officer
|
GrantOption to Purchase Common Stock · Derivative | 450,000 | Not disclosed Strike: $1.92 | Not disclosed |
DisclosureSEC source: 0001731122-24-000263 · ownership.xml · derivative · entry 8 Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2031-06-11 F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 14:06 UTC |
Dybul MarkDirector · Chief Executive Officer
|
Disposition to issuerOption to Purchase Common Stock · Derivative | 450,000 | Not disclosed Strike: $8.00 | Not disclosed |
DisclosureSEC source: 0001731122-24-000263 · ownership.xml · derivative · entry 7 Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 450,000 shares Expires 2031-06-11 F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 14:06 UTC |
Dybul MarkDirector · Chief Executive Officer
|
GrantOption to Purchase Common Stock · Derivative | 300,000 | Not disclosed Strike: $1.92 | Not disclosed |
DisclosureSEC source: 0001731122-24-000263 · ownership.xml · derivative · entry 6 Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2028-11-21 F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 14:06 UTC |
Dybul MarkDirector · Chief Executive Officer
|
Disposition to issuerOption to Purchase Common Stock · Derivative | 300,000 | Not disclosed Strike: $6.50 | Not disclosed |
DisclosureSEC source: 0001731122-24-000263 · ownership.xml · derivative · entry 5 Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 300,000 shares Expires 2028-11-21 F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 14:06 UTC |
Dybul MarkDirector · Chief Executive Officer
|
GrantOption to Purchase Common Stock · Derivative | 5,226 | Not disclosed Strike: $1.92 | Not disclosed |
DisclosureSEC source: 0001731122-24-000263 · ownership.xml · derivative · entry 4 Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,226 Underlying: Common Stock · 5,226 shares Expires 2028-09-19 F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 14:06 UTC |
Dybul MarkDirector · Chief Executive Officer
|
Disposition to issuerOption to Purchase Common Stock · Derivative | 5,226 | Not disclosed Strike: $5.74 | Not disclosed |
DisclosureSEC source: 0001731122-24-000263 · ownership.xml · derivative · entry 3 Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,226 shares Expires 2028-09-19 F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 14:06 UTC |
Dybul MarkDirector · Chief Executive Officer
|
GrantOption to Purchase Common Stock · Derivative | 7,563 | Not disclosed Strike: $1.92 | Not disclosed |
DisclosureSEC source: 0001731122-24-000263 · ownership.xml · derivative · entry 2 Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,563 Underlying: Common Stock · 7,563 shares Expires 2028-02-28 F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 14:06 UTC |
Dybul MarkDirector · Chief Executive Officer
|
Disposition to issuerOption to Purchase Common Stock · Derivative | 7,563 | Not disclosed Strike: $5.95 | Not disclosed |
DisclosureSEC source: 0001731122-24-000263 · ownership.xml · derivative · entry 1 Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,563 shares Expires 2028-02-28 F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options. F1 · derivative.exercise_date: The option vested in three equal installments on February 28, 2019, February 28, 2020 and February 28, 2021. Read SEC document |
| February 13, 2024 Filed Feb 20, 2024 21:20 UTC |
Abildgaard Ole10% owner
|
ConversionSeries A Convertible Preferred Stock · Derivative | 343,619 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-015328 · ownership.xml · derivative · entry 4 Abildgaard Ole · CIK 0001994976 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 3,436,190 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Preferred Stock is convertible into common stock on a 1-for-10 basis. F4 · derivative.expiration_date: The Preferred Stock is perpetual and has no expiration date. F2 · ownership.nature: The reported securities are held directly by Paseco ApS. Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Mr. Abildgaard also directly owns 5,000 shares of the common stock of the issuer. Read SEC document |
| February 13, 2024 Filed Feb 20, 2024 21:20 UTC |
Abildgaard Ole10% owner
|
ConversionCommon Stock | 3,436,190 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-24-015328 · ownership.xml · nonDerivative · entry 1 Abildgaard Ole · CIK 0001994976 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,898,482 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of Series A Convertible Preferred Stock ("Preferred Stock") automatically converted into shares of common stock on a 1-for-10 basis pursuant to their terms upon the closing of the issuer's acquisition of GEDi Cube Int. Ltd. pursuant to that certain Stock Purchase Agreement, dated September 28, 2023, by and among the issuer, GEDi Cube Intl Ltd., the other sellers party thereto, and Yalla Yalla Ltd., in its capacity as the representative of the sellers. F2 · ownership.nature: The reported securities are held directly by Paseco ApS. Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Mr. Abildgaard also directly owns 5,000 shares of the common stock of the issuer. Read SEC document |
| December 27, 2023 Filed Feb 2, 2024 17:14 UTC |
Alton Gregg HDirector
|
GrantOption to purchase shares of common stock · Derivative | 23,810 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001731122-24-000185 · ownership.xml · derivative · entry 1 Alton Gregg H · CIK 0001334682 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,810 Underlying: Common stock · 23,810 shares Expires 2033-12-27 Read SEC document |
| December 27, 2023 Filed Feb 28, 2024 20:20 UTC |
Brosgart Carol LDirector
|
GrantOption to purchase shares of common stock · Derivative | 23,810 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001731122-24-000322 · ownership.xml · derivative · entry 1 Brosgart Carol L · CIK 0001614724 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,810 Underlying: Common stock · 23,810 shares Expires 2033-12-27 Read SEC document |
| October 23, 2023 Filed Nov 14, 2023 09:56 UTC |
Miller AvramDirector
|
GrantOption to purchase shares of common stock · Derivative | 27,147 | $0.00 Strike: $2.76 | $0.00 |
DisclosureSEC source: 0001731122-23-002098 · ownership.xml · derivative · entry 2 Miller Avram · CIK 0002000641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,147 Underlying: Common stock · 27,147 shares Expires 2033-10-11 Read SEC document |
| October 23, 2023 Filed Nov 14, 2023 09:56 UTC |
Miller AvramDirector
|
GrantCommon Stock | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001731122-23-002098 · ownership.xml · nonDerivative · entry 1 Miller Avram · CIK 0002000641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 F1 · date: On October 11, 2023, the Reporting Person entered into an Advisory Agreement, pursuant to which the Issuer agreed to issue Mr. Miller 1,000,000 shares of restricted stock, 166,667 of which will vest in 2024, 444,444 will vest in 2025, and 388,889 will vest in 2026, subject to Mr. Miller's continued service through each applicable vesting date. Read SEC document |
| October 09, 2023 Filed Oct 19, 2023 17:09 UTC |
Gronfeldt-Sorensen HenrikDirector
|
GrantOption to purchase shares of common stock · Derivative | 17,242 | $0.00 Strike: $4.35 | $0.00 |
DisclosureSEC source: 0001731122-23-001919 · ownership.xml · derivative · entry 1 Gronfeldt-Sorensen Henrik · CIK 0001720024 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,242 Underlying: Common stock · 17,242 shares Expires 2033-10-09 Read SEC document |
| October 04, 2023 Filed Oct 25, 2023 14:56 UTC |
Boeren LeniDirector
|
GrantOption to purchase shares of common stock · Derivative | 16,129 | $0.00 Strike: $4.65 | $0.00 |
DisclosureSEC source: 0001731122-23-001947 · ownership.xml · derivative · entry 1 Boeren Leni · CIK 0001998190 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,129 Underlying: Common stock · 16,129 shares Expires 2033-10-04 Read SEC document |
| October 04, 2023 Filed Oct 27, 2023 10:53 UTC |
Hendriks RuudDirector
|
GrantOption to purchase shares of common stock · Derivative | 16,129 | $0.00 Strike: $4.65 | $0.00 |
DisclosureSEC source: 0001731122-23-001972 · ownership.xml · derivative · entry 1 Hendriks Ruud · CIK 0001996999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,129 Underlying: Common stock · 16,129 shares Expires 2033-10-04 Read SEC document |
| October 03, 2023 Filed Feb 20, 2024 21:20 UTC |
Abildgaard Ole10% owner
|
GrantCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-015328 · ownership.xml · nonDerivative · entry 2 Abildgaard Ole · CIK 0001994976 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,398,482 F2 · ownership.nature: The reported securities are held directly by Paseco ApS. Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Mr. Abildgaard also directly owns 5,000 shares of the common stock of the issuer. Read SEC document |
| August 22, 2023 Filed Feb 20, 2024 21:20 UTC |
Abildgaard Ole10% owner
|
GrantCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-015328 · ownership.xml · nonDerivative · entry 3 Abildgaard Ole · CIK 0001994976 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 6,898,482 F2 · ownership.nature: The reported securities are held directly by Paseco ApS. Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Mr. Abildgaard also directly owns 5,000 shares of the common stock of the issuer. Read SEC document |
| August 01, 2023 Filed Sep 12, 2023 10:08 UTC |
Sindlev ReneDirector · 10% owner
|
GrantWarrant (Right to Buy) · Derivative | 350,630 | $0.00 Strike: $0.65 | $0.00 |
DisclosureSEC source: 0001731122-23-001669 · ownership.xml · derivative · entry 2 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By RS Bio ApS Disclosed balance after: 350,630 Underlying: Common Stock · 350,630 shares Expires 2028-08-01 F3 · price: Granted to the Reporting Person as warrant coverage in connection with the Preferred Stock reported above. Read SEC document |
| August 01, 2023 Filed Sep 12, 2023 10:08 UTC |
Sindlev ReneDirector · 10% owner
|
GrantSeries A Convertible Preferred Stock · Derivative | 70,126 | $7.13 Strike: $0.00 | $499,998.38 |
DisclosureSEC source: 0001731122-23-001669 · ownership.xml · derivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By RS Bio ApS Disclosed balance after: 70,126 Underlying: Common Stock · 701,260 shares Expires not disclosed F1 · derivative.exercise_price: The Series A Convertible Preferred Stock ("Preferred Stock") is convertible into Common Stock on a one-for-ten basis F2 · derivative.expiration_date: The Preferred Stock is perpetual and has no expiration date. Read SEC document |
| July 30, 2023 Filed Aug 1, 2023 23:47 UTC |
Sindlev ReneDirector · 10% owner
|
GrantOption to purchase shares of Common Stock · Derivative | 131,579 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001731122-23-001334 · ownership.xml · derivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,579 Underlying: Common Stock · 131,579 shares Expires 2033-07-30 Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 00:29 UTC |
Sindlev ReneDirector · 10% owner
|
GrantWarrant (Right to Buy) · Derivative | 943,397 | $0.00 Strike: $0.53 | $0.00 |
DisclosureSEC source: 0001731122-23-001221 · ownership.xml · derivative · entry 2 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By RS Bio ApS Disclosed balance after: 943,397 Underlying: Common Stock · 943,397 shares Expires 2028-06-26 F1 · price: Granted to the Reporting Person as warrant coverage in connection with the common stock reported on Table I. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 00:29 UTC |
Sindlev ReneDirector · 10% owner
|
GrantCommon Stock | 1,886,794 | $0.53 | $1,000,000.82 |
DisclosureSEC source: 0001731122-23-001221 · ownership.xml · nonDerivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By RS Bio ApS Disclosed balance after: 12,432,338 Read SEC document |
| May 26, 2023 Filed Jun 15, 2023 01:26 UTC |
McNicol JayneDirector
|
GrantOption to Purchase Common Stock · Derivative | 79,787 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001731122-23-001136 · ownership.xml · derivative · entry 1 McNicol Jayne · CIK 0001866827 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,787 Underlying: Common Stock · 79,787 shares Expires 2033-05-26 Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 01:39 UTC |
Sindlev ReneDirector · 10% owner
|
GrantWarrant (Right to Buy) · Derivative | 438,597 | $0.00 Strike: $1.14 | $0.00 |
DisclosureSEC source: 0001731122-23-000444 · ownership.xml · derivative · entry 2 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By RS Bio ApS Disclosed balance after: 438,597 Underlying: Common Stock · 438,597 shares Expires 2028-03-17 F1 · price: Granted to the Reporting Person as warrant coverage in connection with the common stock reported on Table I. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 01:39 UTC |
Sindlev ReneDirector · 10% owner
|
GrantCommon Stock | 877,193 | $1.14 | $1,000,000.02 |
DisclosureSEC source: 0001731122-23-000444 · ownership.xml · nonDerivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By RS Bio ApS Disclosed balance after: 10,545,544 Read SEC document |
| March 06, 2023 Filed Apr 4, 2023 20:07 UTC |
SAPIRSTEIN JAMESDirector
|
GrantOption to Purchase Common Stock · Derivative | 64,655 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001731122-23-000571 · ownership.xml · derivative · entry 1 SAPIRSTEIN JAMES · CIK 0001559509 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,655 Underlying: Common Stock · 64,655 shares Expires 2033-03-06 Read SEC document |
| December 27, 2022 Filed Jan 5, 2023 21:47 UTC |
Brosgart Carol LDirector
|
GrantOption to purchase shares of common stock · Derivative | 57,252 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001731122-23-000019 · ownership.xml · derivative · entry 1 Brosgart Carol L · CIK 0001614724 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,252 Underlying: Common stock · 57,252 shares Expires 2032-12-27 Read SEC document |
| December 27, 2022 Filed Jan 5, 2023 21:48 UTC |
Alton Gregg HDirector
|
GrantOption to purchase shares of common stock · Derivative | 57,252 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001731122-23-000021 · ownership.xml · derivative · entry 1 Alton Gregg H · CIK 0001334682 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,252 Underlying: Common stock · 57,252 shares Expires 2032-12-27 Read SEC document |
| October 18, 2022 Filed Oct 27, 2022 20:54 UTC |
Binette FrancoisExecutive VP for R&D
|
GrantOption to purchase shares of common stock · Derivative | 40,000 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001731122-22-001812 · ownership.xml · derivative · entry 1 Binette Francois · CIK 0001940686 · Executive VP for R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common stock · 40,000 shares Expires 2032-10-18 F1 · derivative.exercise_date: This option vests ratably over three years commencing on October 18, 2023. Read SEC document |
| October 18, 2022 Filed Oct 27, 2022 20:51 UTC |
Puche LuisaChief Financial Officer
|
GrantOption to purchase shares of common stock · Derivative | 80,000 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001731122-22-001810 · ownership.xml · derivative · entry 1 Puche Luisa · CIK 0001768468 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2032-10-18 F1 · derivative.exercise_date: This option vests ratably over three years commencing on October 18, 2023. Read SEC document |
| October 13, 2022 Filed Feb 6, 2023 19:31 UTC |
William Anderson Wittekind10% owner
|
OtherCommon Stock | 1,216,467 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-23-001677 · marketforms-58231.xml · nonDerivative · entry 1 William Anderson Wittekind · CIK 0001753085 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Weird Science LLC Disclosed balance after: 1,313,499 F1 · kind: Shares were received as Earnout Stock pursuant to the Agreement and Plan of Merger dated January 12, 2018 (the "Merger Agreement") by and among the Issuer, its merger sub, Enochian Biopharma Inc. and Weird Science LLC. Weird Science's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the effective date of the closing under the Merger Agreement. F1 · price: Shares were received as Earnout Stock pursuant to the Agreement and Plan of Merger dated January 12, 2018 (the "Merger Agreement") by and among the Issuer, its merger sub, Enochian Biopharma Inc. and Weird Science LLC. Weird Science's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the effective date of the closing under the Merger Agreement. F2 · ownership.nature: The Reporting Person is a manager of Weird Science LLC. Read SEC document |
| October 13, 2022 Filed Feb 7, 2023 00:24 UTC |
Weird Science LLC10% owner
|
OtherCommon Stock | 1,216,467 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-23-001671 · marketforms-58228.xml · nonDerivative · entry 8 Weird Science LLC · CIK 0001955760 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,313,499 F2 · kind: Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement. F2 · price: Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement. Read SEC document |
| October 09, 2022 Filed Oct 26, 2022 20:19 UTC |
Gronfeldt-Sorensen HenrikDirector
|
GrantOption to purchase shares of common stock · Derivative | 45,455 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0001731122-22-001803 · ownership.xml · derivative · entry 1 Gronfeldt-Sorensen Henrik · CIK 0001720024 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,455 Underlying: Common stock · 45.455 shares Expires 2032-10-09 Read SEC document |
| August 25, 2022 Filed Sep 15, 2022 16:36 UTC |
Dybul MarkDirector · Chief Executive Officer
|
GrantOption to purchase shares of common stock · Derivative | 350,000 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0001731122-22-001581 · ownership.xml · derivative · entry 1 Dybul Mark · CIK 0001734805 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common stock · 350,000 shares Expires 2032-08-25 F1 · derivative.exercise_date: The options vest ratably on August 25, 2023, August 25, 2024 and August 25, 2025. Read SEC document |
| July 30, 2022 Filed Oct 25, 2022 20:21 UTC |
Sindlev ReneDirector · 10% owner
|
GrantOption to Purchase Shares of Common Stock · Derivative | 32,609 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001731122-22-001787 · ownership.xml · derivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,609 Underlying: Common Stock · 32,609 shares Expires 2032-07-30 Read SEC document |
| July 20, 2022 Filed Jul 26, 2022 23:02 UTC |
Puche LuisaChief Financial Officer
|
GrantOption to purchase shares of common stock · Derivative | 75,000 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001731122-22-001245 · ownership.xml · derivative · entry 1 Puche Luisa · CIK 0001768468 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common stock · 75,000 shares Expires 2032-07-20 F1 · shares: The option was issued in connection with the Company's employee retention plan. Read SEC document |
| June 08, 2022 Filed Jul 18, 2022 10:02 UTC |
Sindlev ReneDirector · 10% owner
|
OtherCommon Stock | 128,493 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001731122-22-001223 · ownership.xml · nonDerivative · entry 2 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Group ApS Disclosed balance after: 0 F2 · kind: On May 18, 2022, the reporting person entered into a contract to accept shares of the Issuer to satisfy a debt owed to the reporting person. The shares were never delivered to the reporting person and as a result on June 8, 2022 the reporting person terminated the contract. F2 · price: On May 18, 2022, the reporting person entered into a contract to accept shares of the Issuer to satisfy a debt owed to the reporting person. The shares were never delivered to the reporting person and as a result on June 8, 2022 the reporting person terminated the contract. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.